Evidence map›Paper›PMID 30513968›Full record

ReviewViruses2018

Rhabdoviruses, Antiviral Defense, and SUMO Pathway.

Faten El Asmi, Carlos Eduardo Brantis-de-Carvalho, Danielle Blondel, Mounira K Chelbi-Alix

Abstract readReview
In one paragraph

Review in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Faten El AsmiINSERM UMR-S 1124, Université Paris Descartes, 75006 Paris, France. elasmi.faten@gmail.com.
Carlos Eduardo Brantis-de-CarvalhoINSERM UMR-S 1124, Université Paris Descartes, 75006 Paris, France. kdubrantis@icloud.com.
Danielle BlondelInstitute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS UMR 9198, Université Paris-Sud, 91190 Gif-sur-Yvette, France. danielle.blondel@i2bc.paris-saclay.fr.
Mounira K Chelbi-AlixINSERM UMR-S 1124, Université Paris Descartes, 75006 Paris, France. mounira.chelbi-alix@parisdescartes.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small Ubiquitin-like MOdifier (SUMO) conjugation to proteins has essential roles in several processes including localization, stability, and function of several players implicated in intrinsic and innate immunity. In human, five paralogs of SUMO are known of which three are ubiquitously expressed (SUMO1, 2, and 3). Infection by rhabdoviruses triggers cellular responses through the activation of pattern recognition receptors, which leads to the production and secretion of interferon. This review will focus on the effects of the stable expression of the different SUMO paralogs or Ubc9 depletion on rhabdoviruses-induced interferon production and interferon signaling pathways as well as on the expression and functions of restriction factors conferring the resistance to rhabdoviruses.

Indexed as

Signal TransductionAnimalseIF-2 KinaseHumansImmunity, InnateInterferonsMiceMyxovirus Resistance ProteinsProtein BindingRabies virusReceptors, Pattern RecognitionRhabdoviridaeRhabdoviridae InfectionsSmall Ubiquitin-Related Modifier ProteinsSumoylationUbiquitinEIF2AK2 protein, humaneIF-2 KinaseInterferonsMX1 protein, humanMyxovirus Resistance ProteinsReceptors, Pattern RecognitionSmall Ubiquitin-Related Modifier ProteinsUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9IFNinterferonMxAPKRrabies virusSUMOvesicular stomatitis virus

Identifiers

PMID30513968
PMCPMC6316701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.